The U.S. Supreme Court will not hear an appeal from disgraced pharmaceutical executive Martin Shkreli, according to an order released by the justices Monday.
Shkreli’s 2017 conviction on securities fraud and conspiracy charges was upheld in a summary order from the U.S. Court of Appeals for the Second Circuit in July.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]